Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. Pylori Screening and Treatment - AIM 2
NCT07224048Phase 4Completed
- Sponsor
- University of Miami
- Start
- Nov 2024
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Helicobacter pylori infection (2 arms), sponsored by University of Miami. Primary endpoint: Standard vs At-Home Retesting for eradication at 6 weeks. Started Nov 2024; status: completed.
02
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07224048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224048.